Floatz logo

Therapeutic Asset Ratings

502 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Rilvegostomig
Cutaneous Neuroendocrine Carcinoma
AstraZenecaP1/2CC (45)
Torvutatug Samrotecan
Lung Adenocarcinoma
AstraZenecaP1/2CC (45)
Trastuzumab Deruxtecan
Advanced Solid Malignancies
AstraZenecaP1/2CC (45)
Zoladex
High-grade Serous Ovarian Cancer (HGSOC)
AstraZenecaP1/2CC (45)
azd5305
Advanced Solid Malignancies
AstraZenecaP1CC (44)
Capivasertib
Solid Tumour
AstraZenecaP1CC (44)
Ceralasertib
Advanced Solid Malignancies
AstraZenecaP1CC (44)
Cotadutide
Chronic Kidney Disease
AstraZenecaP1CC (44)
Cotadutide
Diabetes Mellitus
AstraZenecaP1CC (44)
Dfn-15
Healthy Volunteers
AstraZenecaP1CC (44)
Itraconazole
Advanced Solid Malignancies
AstraZenecaP1CC (44)
MIDAZOLAM
Solid Tumour
AstraZenecaP1CC (44)
Omeprazole
Healthy Volunteers
AstraZenecaP1CC (44)
(+)-VINCRISTINE
Head and Neck Neoplasms
AstraZenecaP1CC (44)
[111in]-fpi-2107
Non-Small Cell Lung Carcinoma
AstraZenecaP1CC (43)
[111in]-fpi-2107
Colorectal Carcinoma
AstraZenecaP1CC (43)
[225ac]-fpi-2068
Colorectal Carcinoma
AstraZenecaP1CC (43)
azd0022
Advanced Solid Tumours
AstraZenecaP1CC (43)
azd0120
Idiopathic Inflammatory Myopathy
AstraZenecaP1CC (43)
azd0120
Rheumatoid Arthritis
AstraZenecaP1CC (43)
azd0120
Systemic Sclerosis
AstraZenecaP1CC (43)
azd1390
Brain Cancer
AstraZenecaP1CC (43)
azd5305
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
azd5305
Metastatic Neoplasm
AstraZenecaP1CC (43)
azd5335
Primary Peritoneal Carcinoma
AstraZenecaP1CC (43)
Showing 276 to 300 of 502 assets
PreviousPage 12 of 21Next